Detection of BCR-ABL gene sequences using polymerase chain reaction-reverse transcriptase in patients with leukemia;Detección de secuencias del gen BCR-ABL mediante, RT-PCR en pacientes con leucemia en la IX Región. Chile

Revista Medica de Chile

Volumn 130, Issue 6, 2002, Pages 623-630

  Artigas A , Carmen Gloria ^a,b   Melo A , Angélica ^a   Roa S , Juan Carlos ^a   Páez F , Eduardo ^a   Vittini De R , Cecilia ^a   Arriagada M , Monica ^a   Gonzalez O , Luis ^a   Pflaumer F , Erna ^a   Roa E , Iván ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

Author keywords

Leukemia; Oncogene proteins, fusion; Philadelphia chromosome, reverse transcriptase polymerase chain reaction

Indexed keywords

BCR ABL PROTEIN;

ACUTE DISEASE; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHILE; CHRONIC MYELOID LEUKEMIA; FEMALE; GENETICS; HUMAN; INFANT; MALE; MIDDLE AGED; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; ONCOGENE; PRESCHOOL CHILD; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHILE; FEMALE; FUSION PROTEINS, BCR-ABL; GENES, ABL; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0036598197     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. NOWELL PC, HUNGERFORD DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497-500.
2. ROWLEY JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-3.
3. HEISTERKAMP N, STAM K, GROFFEN J, DE KLEIN A, GROSVELD G. Structural organization of the BCR gene and its role in the Ph translocation. Nature 1985; 315: 758-61.
4. DEININGER M, GOLDMAN J, MELO J. The molecular biology of chronic myeloid leukemia. Blood 2000; 96: 3343-56.
5. LAURENT E, TALPAZ M, KANTARJIAN H, KURZROCK R. The BCR Gene and Philadelphia Chromosome-positive Leukemogenesis. Cancer Res 2001; 61: 2343-55.
6. KURZROCK R, GUTTERMAN J, TALPAZ M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988; 319: 990-8.
7. MAURER J, JANSSEN JW, THIEL E, VAN DENDEREN J, LUDWIG WD, AYDEMIR U ET AL. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055-8.
8. MELO JV, GORDON DE, TUSZYNSKI A, DHUT S, YOUNG BD, GOLDMAN JM. Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia. Blood 1993; 81: 2488-91.
9. PANE F, FRIGERI F, SINDONA M, LUCIANO L, FERRARA F, CIMINO R ET AL. Neutrophilic-Chronic Myeloid Leukemia: A distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410-4.
10. LISKER R. El cromosoma Philadelphia. En: Ruiz-Argüelles GJ, San Miguel JF. Actualización en Leucemias. México DF: Editorial Médica Panamericana, 1996; 97-106.
11. SÁNCHEZ-GARCÍA I, GRÜTZ G. The tumorigenic activity of the BCR-ABL genes is mediated by BCL-2. Proc Natl Acad USA 1995; 92: 5287-91.
12. COBALEDA C, GUTIÉRREZ-CIANCA J, PÉREZ-LOSADA T, FLORES R, GARCÍA-SANZ M, GONZÁLEZ M ET AL. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood 2000; 95: 1007-13.
13. KAWAGUCHI Y, JINNAI I, NAGAI K, YAGASAKI F, YAKATA Y, MATSUO T ET AL. Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells. Leukemia 2001; 15: 590-4.
14. BUCHDUNGER E, ZIMMERMANN J, METT H, MEYER T, MULLER M, REGENASS U ET AL. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci USA 1995; 92: 2558-62.
15. CROSS N, HUGHES T, FENG L, O'SHEA P, BUNGEY J, MARKS D ET AL. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlation with acute graft-versus-host disease and relapse. Br J Haemat 1993; 84: 67-74.
16. FADERL S, TALPAZ M, ESTROV Z, O'BRIEN S, KURZ-ROCK R, KANTARJIAN H. The biology of chronic myeloid leukemia. N Engl J Med 1999; 341: 164-72.
17. EREN E, AYTAC U, TETIK E, AKMAN O, KANSU E, GUNDUZ U. Detection of BCR-ABL gene rearrangement and the elimination of rearranged clone in chronic myelocytic leukemia patients. Am J Hematol 2000; 63: 85-9.
18. RADICH JP, GEHLY G, GOOLEY T, BRYANT E, CLIFT RA, COLLINS S ET AL. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 1995; 85: 2632-8.
19. SERRANO J, ROMÁN J, SÁNCHEZ J, JIMÉNEZ A, CASTILLEJO J, HERRERA C ET AL. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BRC-ABL and p190BCR-ABL after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190BCR-ABL detection precede cytogenetic relapse. Blood 2000; 95: 2659-65.
20. BEYERMANN B, AGTHE A, ADAMS H, SEEGER K, LINDERKAMP C, GOETZE G ET AL. Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. Blood 1996; 87: 1532-8.
21. WESTBROOK C, HOOBERMAN A, SPINO C, DODGE R, LARSON R, DAVEY F ET AL. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762). Blood 1992; 80: 2983-90.
22. FLETCHER JA, LYNCH EA, KIMBALL VM, DONNELLY M, TANTRAVAHI R, SALLAN SE. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991; 77: 435-9.
23. BEYERMANN B, ADAMS HP, HENZE G. Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia; a matched-pair analysis. J Clin Oncol 1997; 15: 2231-7.
24. RAMBALDI A, ATTUATI V, BASSAN R, NEONATO MG, VIERO P, BATTISTA R ET AL. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia. Leuk Lymphoma 1996; 21: 457-66.
25. PAIETTA E, RACEVSKIS J, BENNETT JM, NEUBERG D, CASSILETH PA, ROWE JM ET AL. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia 1998; 12: 1881-5.
26. CARBONELL F, SWANSBURY J, MIN T, MATUTES E, FARAHAT N, BUCCHERI V ET AL. Cytogenetic findings in acute biphenotypic leukaemia. Leukemia 1996; 10: 1283-7.
27. KILLICK S, MATUTES E, POWLES RL, HAMBLIN M, SWANSBURY J, TRELEAVEN JG ET AL. Outcome of biphenotypic acute leukemia. Haematologica 1999; 84: 699-706.
28. CROSS N. Detection of BCR-ABL in Hematological Malignancies by RT-PCR. En: Cotter F. Molecular diagnosis of cancer. Totowa, New Jersey: Humana Press 1996; 25-36.
29. VAN DONGEN JJ, MACINTYRE EA, GABERT JA, DELABESSE E, ROSSI V, SAGLIO G ET AL. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901-28.
30. LIRA P, BARRIGA F, RISUEÑO C, ALFARO J, LEGÜES ME, GREBE G. Leucemia mieloide crónica: estudio citogenético y molecular y su relación con la evolución de la enfermedad. Rev Méd Chile 1993; 121: 864-72.
31. LEGUES ME, CAMPBELL M, CABRERA ME, VARGAS L, BECKER A, SALGADO C ET AL. Estudios citogenéticos en niños chilenos con leucemia linfoblástica aguda. Rev Méd Chile 1994; 122: 1239-47.
32. LIN F, GOLDMAN JM, CROSS N. A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia. Br J Haematol 1994; 86: 683-5.
33. CHOMCZYNSKI P, SACCHI N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical biochemistry 1987; 162: 156-9.
34. ARTIGAS CG, MELO A. Gen DRB-1: Su utilidad como control interno en la técnica de reacción en cadena de la polimerasa con transcriptasa reversa (RT-PCR). Rev Chil Cs Méd Biol 2000; 10: 47-50.
35. LICHTY BD, KEATING A, CALLUM J, YEE K, CROXFORD R, CORPUS G ET AL. Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia. Br J Haematol 1998; 103: 711-5.
36. TANAKA M, YAMAZAKI Y, HATTORI M, TSUSHITA K, UTSUMI M, YOSHIDA S. The dual expression of minor and major BCR-ABL chimeric mRNA in blast crisis of chronic myelogenous leukemia. Leuk Res 1996; 20: 575-80.
37. KANTARJIAN HM, TALPAZ M, DHINGRA K, ESTEY E, KEATING MJ, Ku S ET AL. Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991; 78: 2411-8.
38. OSORIO G, MUÑOZ L. Leucosis mieloide crónica. En: Osorio G. Hematología, Diagnóstico y Terapéutica. Santiago. Publicaciones Técnicas Méditerráneo, 1997; 206-19.
39. VAN RHEE F, HOCHHAUS A, LIN F, MELO JV, GOLDMAN JM, CROSS N. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood 1996; 87: 5213-7.
40. SAGLIO G, PANE F, GOTTARDI E, FRIGERI F, BUONAIUTO MR, GUERRASIO A ET AL. Consistent amounts of acute leukemia-associated p190BCR-ABL transcript are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 1996; 87: 1075-80.